Kalaris Therapeutics Inc

NASDAQ: KLRS · Real-Time Price · USD
2.46
0.19 (8.37%)
At close: Aug 15, 2025, 3:55 PM
2.42
-1.43%
After-hours: Aug 15, 2025, 04:10 PM EDT

Kalaris Therapeutics Inc Ratios and Metrics

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2023 FY 2022
Period Ending Dec 31, 2023 Dec 31, 2022
PE Ratio
n/a n/a
PEG Ratio
n/a n/a
PS Ratio
n/a n/a
PB Ratio
n/a n/a
P/FCF Ratio
n/a n/a
P/OCF Ratio
n/a n/a
OCF/S Ratio
n/a n/a
Debt / Equity Ratio
n/a -0.11
Quick Ratio
0.85 0.69
Current Ratio
0.85 0.69
Asset Turnover
n/a n/a
Interest Coverage
-19.6 -59.6
Return on Equity
0.33 0.51
Return on Assets
-4.41 -3.97
Return on Invested Capital
22.11 7.82
Dividend Yield
n/a n/a
Payout Ratio
n/a n/a
Gross Profit Margin
n/a n/a
Net Profit Margin
n/a n/a
Pretax Profit Margin
n/a n/a
Operating Profit Margin
n/a n/a
FCF Margin
n/a n/a
EBITDA Margin
n/a n/a